Skip to main content
Premium Trial:

Request an Annual Quote

Premaitha Raises £3M in Accelerated Stock Offering

NEW YORK (GenomeWeb) – Premaitha Health said today that it has raised £3 million ($3.9 million) in gross proceeds from a previously announced stock offering.

The UK-based noninvasive prenatal testing company said that the proceeds from this accelerated bookbuild offering come from two tranches — 22 million new ordinary shares offered as part of a placement and 8 million new ordinary shares as part of a subscription, all sold at 10 pence per share.

The placing and subscription shares are expected to start trading on the AIM market of the London Stock Exchange this month, with the first tranche of shares becoming effective around Oct, 4 and the second tranche of shares around Oct. 25.

"We are pleased with the support of both existing and new investors," Premaitha Non-Executive Chairman Adam Reynolds said in a statement. "The fundraising will enable us to move on from the litigation [with Illumina] and to execute on our strategy of becoming a truly global player, capturing a growing share of a multi-billion dollar market for noninvasive prenatal testing."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.